Peroxisome proliferator-activated receptor-γ coactivator-1 and insulin resistance: acute effect of fatty acids

Author： Hoeks J. Hesselink M. Russell A. Mensink M. Saris W. Mensink R. Schrauwen P.

ISSN： 0012-186X

Source： Diabetologia, Vol.49, Iss.10, 2006-10, pp. : 2419-2426

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Selective Peroxisome Proliferator-Activated Receptor-γ Modulation to Reduce Cardiovascular Risk in Patients with Insulin Resistance

Recent Patents on Cardiovascular Drug Discovery, Vol. 7, Iss. 1, 2012-04 ,pp. : 33-41

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator Activated Receptor-γ (PPAR-γ) Ligands and Angiogenesis

By Margeli A. Kouraklis G. Theocharis S.

Angiogenesis, Vol. 6, Iss. 3, 2003-01 ,pp. : 165-169

Springer Publishing Company

Access to resources Recommend Favorite

Selective Peroxisome Proliferator-Activated Receptor-γ Modulation in the Treatment of Hypertension and Metabolic Syndrome: The Role of Angiotensin II Receptor Blockers

By Borghi Claudio

High Blood Pressure & Cardiovascular Prevention, Vol. 13, Iss. 3, 2006-01 ,pp. : 81-84

Adis International

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor-γ Pro12Ala Polymorphism and Risk of Osteopenia in β-Thalassemia Major Patients

By Sahmani Mehdi Gholami Abdollah Azarkeivan Azita Darabi Masoud Ahmadi Mohammad Hossein Sabet Majid Sirati Najafipour Reza

Hemoglobin, Vol. 37, Iss. 6, 2013-12 ,pp. : 564-573

Informa Healthcare

Access to resources Recommend Favorite

Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ gene in women with polycystic ovary syndrome

By Yilmaz Murat Ali Ergün Mehmet Karakoç Ayhan Yurtçu Erkan Çakir Nuri Arslan Metin

Gynecological Endocrinology, Vol. 22, Iss. 6, 2006-06 ,pp. : 336-342

Informa Healthcare

Access to resources Recommend Favorite